Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Angiotensin Receptor Antagonists market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Angiotensin Receptor Antagonistsmarket, defines the market attractiveness level of Angiotensin Receptor Antagonists market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Angiotensin Receptor Antagonists industry, describes the types of Angiotensin Receptor Antagonists market, the applications of major players and the market size, and deeply analyzes the current situation of the global Angiotensin Receptor Antagonists market and the development prospects and opportunities of Angiotensin Receptor Antagonists industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Angiotensin Receptor Antagonists market in Chapter 13.
By Player:
Pfizer
Merck
Bristol-Myers Squibb
Teva Pharmaceutical
Novartis
Jhonson and Johnson
Astra Zeneca
Bayer
Sanofi SA
Eli Lilly and Company
GSK
By Type:
Valsartan
Telmisartan
Losartan
Irbesartan
Azilsartan
Olmesartan
By End-User:
Hypertension
Cardiovascular Diseases
Kidney Diseases
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Angiotensin Receptor Antagonists Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Angiotensin Receptor Antagonists Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Angiotensin Receptor Antagonists Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Angiotensin Receptor Antagonists Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Angiotensin Receptor Antagonists Market Analysis and Outlook to 2022
-
7.1 Global Angiotensin Receptor Antagonists Consumption (2017-2022)
-
7.2 United States Angiotensin Receptor Antagonists Consumption (2017-2022)
-
7.3 Europe Angiotensin Receptor Antagonists Consumption (2017-2022)
-
7.4 China Angiotensin Receptor Antagonists Consumption (2017-2022)
-
7.5 Japan Angiotensin Receptor Antagonists Consumption (2017-2022)
-
7.6 India Angiotensin Receptor Antagonists Consumption (2017-2022)
-
7.7 South Korea Angiotensin Receptor Antagonists Consumption (2017-2022)
8 Region and Country-wise Angiotensin Receptor Antagonists Market Analysis and Outlook to 2028
-
8.1 Global Angiotensin Receptor Antagonists Consumption Forecast (2022-2028)
-
8.2 United States Angiotensin Receptor Antagonists Consumption Forecast (2022-2028)
-
8.3 Europe Angiotensin Receptor Antagonists Consumption Forecast (2022-2028)
-
8.4 China Angiotensin Receptor Antagonists Consumption Forecast (2022-2028)
-
8.5 Japan Angiotensin Receptor Antagonists Consumption Forecast (2022-2028)
-
8.6 India Angiotensin Receptor Antagonists Consumption Forecast (2022-2028)
-
8.7 South Korea Angiotensin Receptor Antagonists Consumption Forecast (2022-2028)
9 Global Angiotensin Receptor Antagonists Market Outlook by Types and Applications to 2022
-
9.1 Global Angiotensin Receptor Antagonists Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Valsartan Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Telmisartan Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Losartan Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Irbesartan Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Azilsartan Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Olmesartan Consumption and Growth Rate (2017-2022)
-
9.2 Global Angiotensin Receptor Antagonists Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hypertension Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Kidney Diseases Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Angiotensin Receptor Antagonists Market Outlook by Types and Applications to 2028
-
10.1 Global Angiotensin Receptor Antagonists Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Valsartan Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Telmisartan Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Losartan Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Irbesartan Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Azilsartan Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Olmesartan Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Angiotensin Receptor Antagonists Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hypertension Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Kidney Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Angiotensin Receptor Antagonists Import and Export Analysis (Top 5 Countries)
-
11.1 Global Angiotensin Receptor Antagonists Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Angiotensin Receptor Antagonists Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Angiotensin Receptor Antagonists Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Angiotensin Receptor Antagonists Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Angiotensin Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Angiotensin Receptor Antagonists Product and Service
-
14.2 Merck
-
14.2.1 Merck Company Details
-
14.2.2 Merck Angiotensin Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Merck Angiotensin Receptor Antagonists Product and Service
-
14.3 Bristol-Myers Squibb
-
14.3.1 Bristol-Myers Squibb Company Details
-
14.3.2 Bristol-Myers Squibb Angiotensin Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bristol-Myers Squibb Angiotensin Receptor Antagonists Product and Service
-
14.4 Teva Pharmaceutical
-
14.4.1 Teva Pharmaceutical Company Details
-
14.4.2 Teva Pharmaceutical Angiotensin Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Teva Pharmaceutical Angiotensin Receptor Antagonists Product and Service
-
14.5 Novartis
-
14.5.1 Novartis Company Details
-
14.5.2 Novartis Angiotensin Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novartis Angiotensin Receptor Antagonists Product and Service
-
14.6 Jhonson and Johnson
-
14.6.1 Jhonson and Johnson Company Details
-
14.6.2 Jhonson and Johnson Angiotensin Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Jhonson and Johnson Angiotensin Receptor Antagonists Product and Service
-
14.7 Astra Zeneca
-
14.7.1 Astra Zeneca Company Details
-
14.7.2 Astra Zeneca Angiotensin Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Astra Zeneca Angiotensin Receptor Antagonists Product and Service
-
14.8 Bayer
-
14.8.1 Bayer Company Details
-
14.8.2 Bayer Angiotensin Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Bayer Angiotensin Receptor Antagonists Product and Service
-
14.9 Sanofi SA
-
14.9.1 Sanofi SA Company Details
-
14.9.2 Sanofi SA Angiotensin Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Sanofi SA Angiotensin Receptor Antagonists Product and Service
-
14.10 Eli Lilly and Company
-
14.10.1 Eli Lilly and Company Company Details
-
14.10.2 Eli Lilly and Company Angiotensin Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Eli Lilly and Company Angiotensin Receptor Antagonists Product and Service
-
14.11 GSK
-
14.11.1 GSK Company Details
-
14.11.2 GSK Angiotensin Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 GSK Angiotensin Receptor Antagonists Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Angiotensin Receptor Antagonists
-
Figure Angiotensin Receptor Antagonists Picture
-
Table Global Angiotensin Receptor Antagonists Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Angiotensin Receptor Antagonists Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Angiotensin Receptor Antagonists Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Angiotensin Receptor Antagonists Consumption by Country (2017-2022)
-
Figure United States Angiotensin Receptor Antagonists Consumption and Growth Rate (2017-2022)
-
Table Europe Angiotensin Receptor Antagonists Consumption and Growth Rate (2017-2022)
-
Figure China Angiotensin Receptor Antagonists Consumption and Growth Rate (2017-2022)
-
Figure Japan Angiotensin Receptor Antagonists Consumption and Growth Rate (2017-2022)
-
Figure India Angiotensin Receptor Antagonists Consumption and Growth Rate (2017-2022)
-
Figure South Korea Angiotensin Receptor Antagonists Consumption and Growth Rate (2017-2022)
-
Figure Global Angiotensin Receptor Antagonists Consumption Forecast by Country (2022-2028)
-
Figure United States Angiotensin Receptor Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Angiotensin Receptor Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Angiotensin Receptor Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Angiotensin Receptor Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Angiotensin Receptor Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Angiotensin Receptor Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Valsartan Consumption and Growth Rate (2017-2022)
-
Figure Global Telmisartan Consumption and Growth Rate (2017-2022)
-
Figure Global Losartan Consumption and Growth Rate (2017-2022)
-
Figure Global Irbesartan Consumption and Growth Rate (2017-2022)
-
Figure Global Azilsartan Consumption and Growth Rate (2017-2022)
-
Figure Global Olmesartan Consumption and Growth Rate (2017-2022)
-
Figure Global Hypertension Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Kidney Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Valsartan Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Telmisartan Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Losartan Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Irbesartan Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Azilsartan Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Olmesartan Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hypertension Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kidney Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Angiotensin Receptor Antagonists Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Angiotensin Receptor Antagonists Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Angiotensin Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Angiotensin Receptor Antagonists Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Angiotensin Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Angiotensin Receptor Antagonists Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Angiotensin Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Angiotensin Receptor Antagonists Product and Service
-
Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Angiotensin Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Angiotensin Receptor Antagonists Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Angiotensin Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Angiotensin Receptor Antagonists Product and Service
-
Table Jhonson and Johnson (Foundation Year, Company Profile and etc.)
-
Table Jhonson and Johnson Angiotensin Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jhonson and Johnson Angiotensin Receptor Antagonists Product and Service
-
Table Astra Zeneca (Foundation Year, Company Profile and etc.)
-
Table Astra Zeneca Angiotensin Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astra Zeneca Angiotensin Receptor Antagonists Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Angiotensin Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Angiotensin Receptor Antagonists Product and Service
-
Table Sanofi SA (Foundation Year, Company Profile and etc.)
-
Table Sanofi SA Angiotensin Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi SA Angiotensin Receptor Antagonists Product and Service
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Angiotensin Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Angiotensin Receptor Antagonists Product and Service
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK Angiotensin Receptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Angiotensin Receptor Antagonists Product and Service
-
